Cardima CE marks surgical ablation probe for atrial fibrillation
This article was originally published in Clinica
Cardiology specialist Cardima has CE marked its surgical ablation probe for sale in Europe. The probe is part of the firm's surgical ablation system, which is used to treat atrial fibrillation. The system can be employed in open-chest surgery in combination with other procedures, or alone in less-invasive, closed-chest procedures. During the latter, Cardima's system allows cardiac surgeons to gain access to the heart via "two or three small ports in the chest". The system also treats both the left and right aortas, which Cardima (Fremont, California) believes is necessary for successful treatment. The system is already approved by the US FDA for the ablation of cardiac tissue.